Interferon-Alpha for Diabetes Mellitus Type 1

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Insulin-Dependent Diabetes Mellitus
Interventions
DRUG

30,000 units hrINF-alpha

DRUG

5,000 hrINF-alpha

OTHER

Placebo

placebo was prepared as saline alone with 6mg human serum albumin (HSA).

Trial Locations (5)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

75216

University of Texas, Dallas, Dallas

77030

University of Texas, Houston, Houston

Unknown

Children's Hospital - St. Paul, Saint Paul

Children's Hospital - Kansas City, Kansas City

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

The University of Texas Health Science Center, Houston

OTHER

NCT00024518 - Interferon-Alpha for Diabetes Mellitus Type 1 | Biotech Hunter | Biotech Hunter